ABSTRACT
The decision to accept a deceased donor organ offer for transplant, or wait for something potentially better in the future, can be challenging. Clinical decision support tools predicting transplant outcomes are lacking. This project uses interpretable methods to predict both graft failure and patient death using data from previously accepted kidney transplant offers. Using more than twenty years of transplant outcome data, we train and compare several survival analysis models in single risk settings. In addition, we use post hoc interpretability techniques to clinically validate these models. Neural networks show comparable performance to the Cox proportional hazard model, with concordance of 0.63 and 0.79 for prediction of graft failure and patient death, respectively. Recipient and donor ages, primary renal disease, the number of mismatches at DR locus, and calculated reaction frequency at transplant appear to be important features for transplant outcome prediction. Owing to their good predictive performance and the clinical relevance of their post hoc interpretation, neural networks represent a promising core component in the construction of future decision support systems for transplant offering.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work has been supported by funds from the NIHR (AI Award 2020 Phase 1: AI_AWARD02316). T.Z. was supported by the Royal Academy of Engineering under the Research Fellowship scheme.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study, referenced under IRAS project ID 304542, has received approval from the Health Research Authority and Health and Care Research Wales (UK research ethics committee).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
(simon.knight{at}nds.ox.ac.uk)
(lrwingfield{at}gmail.com)
(tingting.zhu{at}eng.ox.ac.uk)
We have changed our approach to survival analysis rather than classification modelling. However, neither the motivation nor the main conclusions of this article are changed
